OBJECTIVE: To evaluate the value of alternative monotherapy versus adjunctive therapy in partial epilepsy refractory to single antiepileptic drug (AED) therapy. DESIGN AND METHODS: In a multicentre, parallel-group, open-label study, patients with cryptogenic or symptomatic partial epilepsy not controlled after single or sequential AED monotherapies were randomised to monotherapy with an alternative AED or to adjunctive therapy with a second AED. The AED to be added/substituted and dose adjustments were determined by the physician's best judgement. Patients were followed up until withdrawal from the allocated treatment or for 12 months, whichever first. Outcome measures included proportion of patients continuing on the assigned treatment str...
BackgroundEpilepsy is a common neurological condition with a worldwide prevalence of around 1%. Appr...
AbstractPurposeAdverse effects of anti epileptic drugs (AEDs) can significantly affect the life of p...
Regulatory requirements to demonstrate the efficacy of novel antiepileptic drugs (AEDs) as monothera...
Abstract: Antiepileptic drug (AED) monotherapy is the preferred initial management approach in epile...
A total of 97 patients were recruited into a prospective, follow-up study after they were prescribed...
Background. Monotherapy is the choice regimen to treat newly diagnosed epilepsies. However, if it fa...
Abstract: While several newer AEDs have study data that support monotherapy usage, most possess FDA ...
PURPOSE: Monotherapy has been the gold standard in epilepsy treatment for the last 20 years, partly ...
A number of clinical trials that test the efficacy and safety of the newer antiepileptic drugs (AEDs...
Designing monotherapy trials in epilepsy is fraught with many hurdles, including diagnostic and clas...
Antiepiletic drugs are about equally efficacious in suppressing epileptic seizures,however they do d...
AbstractThe objective of this study was to compare the relative cost-effectiveness of two AEDs by a ...
Traditional randomized clinical trials for the monotherapy assessment of antiepileptic drugs (AED) i...
Item does not contain fulltextPolytherapy with antiepileptic drugs is not popular mainly because it ...
Although new antiepileptic drugs are assessed initially by adding them to pre-existing treatment, it...
BackgroundEpilepsy is a common neurological condition with a worldwide prevalence of around 1%. Appr...
AbstractPurposeAdverse effects of anti epileptic drugs (AEDs) can significantly affect the life of p...
Regulatory requirements to demonstrate the efficacy of novel antiepileptic drugs (AEDs) as monothera...
Abstract: Antiepileptic drug (AED) monotherapy is the preferred initial management approach in epile...
A total of 97 patients were recruited into a prospective, follow-up study after they were prescribed...
Background. Monotherapy is the choice regimen to treat newly diagnosed epilepsies. However, if it fa...
Abstract: While several newer AEDs have study data that support monotherapy usage, most possess FDA ...
PURPOSE: Monotherapy has been the gold standard in epilepsy treatment for the last 20 years, partly ...
A number of clinical trials that test the efficacy and safety of the newer antiepileptic drugs (AEDs...
Designing monotherapy trials in epilepsy is fraught with many hurdles, including diagnostic and clas...
Antiepiletic drugs are about equally efficacious in suppressing epileptic seizures,however they do d...
AbstractThe objective of this study was to compare the relative cost-effectiveness of two AEDs by a ...
Traditional randomized clinical trials for the monotherapy assessment of antiepileptic drugs (AED) i...
Item does not contain fulltextPolytherapy with antiepileptic drugs is not popular mainly because it ...
Although new antiepileptic drugs are assessed initially by adding them to pre-existing treatment, it...
BackgroundEpilepsy is a common neurological condition with a worldwide prevalence of around 1%. Appr...
AbstractPurposeAdverse effects of anti epileptic drugs (AEDs) can significantly affect the life of p...
Regulatory requirements to demonstrate the efficacy of novel antiepileptic drugs (AEDs) as monothera...